losoxantrone has been researched along with mitoxantrone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elslager, EF; Jackson, RC; Johnson, JL; Leopold, WR; Showalter, HD; Werbel, LM | 1 |
| Guziec, FS; Guziec, LJ; Hasinoff, BB; Liang, H; Marshall, K; Wu, X; Yalowich, JC | 1 |
| Fisher, GR; Patterson, LH | 1 |
| Gatto, B; Krapcho, AP; Menta, E; Moro, S; Palumbo, M; Richter, S; Sissi, C; Spinelli, S; Zunino, F | 1 |
4 other study(ies) available for losoxantrone and mitoxantrone
| Article | Year |
|---|---|
5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation.
Topics: Animals; Anthraquinones; Antibiotics, Antineoplastic; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone | 1984 |
The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds.
Topics: Anthracyclines; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cell Survival; DNA; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Neoplasms; Nucleic Acid Denaturation; Plasmids; Protein Binding; Quantitative Structure-Activity Relationship; Temperature; Topoisomerase II Inhibitors | 2008 |
Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.
Topics: Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Cell Death; DNA, Neoplasm; Doxorubicin; Humans; Mitoxantrone; Oxidation-Reduction; Pyrazoles; Pyrazolones; Reactive Oxygen Species; Tumor Cells, Cultured | 1992 |
DNA-interactive anticancer aza-anthrapyrazoles: biophysical and biochemical studies relevant to the mechanism of action.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Base Sequence; Binding Sites; Cattle; Clostridium perfringens; Deoxyribonuclease I; DNA; DNA Footprinting; DNA Topoisomerases, Type II; DNA, Viral; Fluorometry; Intercalating Agents; Micrococcus; Mitoxantrone; Models, Molecular; Molecular Sequence Data; Oxidation-Reduction; Plasmids; Pyrazoles; Pyrazolones; Thymus Gland | 2001 |